Zobrazeno 1 - 10
of 836
pro vyhledávání: '"Reverse Transcriptase Inhibitors/administration '
Autor:
Cheng, Nanfang, Cheng, Xinyuan, Tan, Feng, Liang, Yangui, Xu, Lihong, Wang, Jian, Tan, Jiuqing
Publikováno v:
Acupuncture in Medicine; Jun2024, Vol. 42 Issue 3, p133-145, 13p
Autor:
Somboon Tansuphasawadikul, David A. Cooper, Umaporn Siangphoe, Phitsanu Raksakulkarn, Kiat Ruxrungtham, Andrew F. Hill, Warangkana Munsakul, Sasisopin Kiertiburanakul, Ploenchan Chetchotisakd, Reto Nüesch, Wisit Prasithsirikul, Bernard Hirschel, Jintanat Ananworanich
Publikováno v:
Scopus-Elsevier
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
ObjectiveTo assess the efficacy and safety of first-line treatment with once-daily saquinavir/ritonavir with two nucleoside reverse transcriptase inhibitors (NRTIs), as induction therapy before enrollment in a randomized trial of structured treatment
Autor:
Alexandra U, Scherrer, Viktor, von Wyl, Jürg, Böni, Sabine, Yerly, Thomas, Klimkait, Philippe, Bürgisser, Christian, Garzoni, Bernard, Hirschel, Matthias, Cavassini, Manuel, Battegay, Pietro L, Vernazza, Enos, Bernasconi, Bruno, Ledergerber, Huldrych F, Günthard, S, Yerly
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes; Vol 57
Journal of Acquired Immune Deficiency Syndromes, Vol. 57, No 1 (2011) pp. 24-31
Journal of Acquired Immune Deficiency Syndromes, Vol. 57, No 1 (2011) pp. 24-31
Nucleoside reverse transcriptase inhibitors (NRTIs) are often administered in salvage therapy even if genotypic resistance tests (GRTs) indicate high-level resistance, but little is known about the benefit of these additional NRTIs.The effect of2 com
Autor:
Federico Pulido, Janak Koirala, Carlos Brites, Jens Lundgren, Pablo Okhuysen, DAVID DALMAU, Clifford Leen, Matti Ristola, Lorenzo Magenta, Lars Østergaard, Sean Emery, Angèle Gayet-Ageron, Michael Kozal, André Cabié, Nicholas Andrew Medland, Philippa Easterbrook
Publikováno v:
Fox, Z, Phillips, A, Cohen, C, Neuhaus, J, Baxter, J, Emery, S, Hirschel, B, Hullsiek, K H, Stephan, C, Lundgren, J, SMART Study Group & Østergaard, L J 2008, ' Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen ', AIDS, vol. 22, no. 17, pp. 2279-89 . https://doi.org/10.1097/QAD.0b013e328311d16f
AIDS, Vol. 22, No 17 (2008) pp. 2279-2289
AIDS, Vol. 22, No 17 (2008) pp. 2279-2289
Udgivelsesdato: 2008-Nov-12 BACKGROUND: Interruption of a non-nucleoside reverse transcriptase inhibitor (NNRTI)-regimen is often necessary, but must be performed with caution because NNRTIs have a low genetic barrier to resistance. Limited data exis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e70a8e3c1abb9bad797a3b08920f59
https://pure.au.dk/portal/da/publications/viral-resuppression-and-detection-of-drug-resistance-following-interruption-of-a-suppressive-nonnucleoside-reverse-transcriptase-inhibitorbased-regimen(1cf79d10-025c-11de-a987-000ea68e967b).html
https://pure.au.dk/portal/da/publications/viral-resuppression-and-detection-of-drug-resistance-following-interruption-of-a-suppressive-nonnucleoside-reverse-transcriptase-inhibitorbased-regimen(1cf79d10-025c-11de-a987-000ea68e967b).html
Autor:
Scherrer, Alexandra U., Böni, Jürg, Yerly, Sabine, Klimkait, Thomas, Aubert, Vincent, Furrer, Hansjakob, Calmy, Alexandra, Cavassini, Matthias, Elzi, Luigia, Vernazza, Pietro L., Bernasconi, Enos, Ledergerber, Bruno, Günthard, Huldrych F., Swiss HIV Cohort Study (SHCS)
Publikováno v:
Scherrer, Alexandra U.; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L.; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F.; Swiss HIV Cohort Study (SHCS), (2012). Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PLoS ONE, 7(11), e50307. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0050307
PLOS ONE, Vol. 7, No 11 (2012) P. e50307
Plos One, vol. 7, no. 11, pp. e50307
PLoS ONE
PLoS ONE, Vol 7, Iss 11, p e50307 (2012)
PloS one
PLoS ONE; Vol 7
PLOS ONE, Vol. 7, No 11 (2012) P. e50307
Plos One, vol. 7, no. 11, pp. e50307
PLoS ONE
PLoS ONE, Vol 7, Iss 11, p e50307 (2012)
PloS one
PLoS ONE; Vol 7
BACKGROUND: The accumulation of mutations after long-lasting exposure to a failing combination antiretroviral therapy (cART) is problematic and severely reduces the options for further successful treatments. METHODS: We studied patients from the Swis
Autor:
Xu, WENda1, Wang, Weixing1 wangweixingrmh@sina.com
Publikováno v:
Molecular Medicine Reports. Jun2018, Vol. 17 Issue 6, p7529-7536. 8p.
Autor:
Nathan Ford, Nicholas I. Paton, María Eugenia Socías, Evan Popoff, Keith Chan, Meg Doherty, Steve Kanters, Dieter Ayers, Matthew O. Wiens, Edward J Mills, Alexandra Calmy, Marco Vitoria, David A. Cooper, Sabin Nsanzimana
Publikováno v:
The Lancet HIV, Vol. 4, No 10 (2017) pp. e433-e441
Summary Background Selection of optimal second-line antiretroviral therapy (ART) has important clinical and programmatic implications. To inform the 2016 revision of the WHO ART guidelines, we assessed the comparative effectiveness and safety of avai
Autor:
Guo, Yuanyuan, Li, Zhong, Cao, Zhenxue, Ma, Tantu, Mei, Juan, Sun, Wei, Gao, Wuyue, Liu, Beibei, Liu, Jianmin, Wang, Rui
Publikováno v:
European Journal of Inflammation; 10/15/2021, p1-10, 10p
Publikováno v:
Investigational New Drugs; Jun2022, Vol. 40 Issue 3, p506-518, 13p
Autor:
Ciaffi, Laura, Koulla-Shiro, Sinata, Sawadogo, Adrien Bruno, Ndour, Cheik Tidiane, Eymard-Duvernay, Sabrina, Mbouyap, Pretty Rosereine, Ayangma, Liliane, Zoungrana, Jacques, Gueye, Ndeye Fatou Ngom, Diallo, Mohamadou, Izard, Suzanne, Bado, Guillaume, Kane, Coumba Toure, Aghokeng, Avelin Fobang, Peeters, Martine, Girard, Pierre Marie, Le Moing, Vincent, Reynes, Jacques, Delaporte, Eric, Calmy, Alexandra
Publikováno v:
The Lancet HIV, Vol. 4, No 9 (2017) pp. e384-e392
Despite satisfactory efficacy of WHO-recommended second-line antiretroviral treatment for patients with HIV in low-income countries, the need for simplified, low-cost, and less-toxic maintenance strategies remains high. We compared boosted protease i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::f50a2833cd6e4e66de0d0bb271f15a97
https://archive-ouverte.unige.ch/unige:112376
https://archive-ouverte.unige.ch/unige:112376